A first in autism: artificial intelligence helps identify children for whom bumetanide could be considered as a treatment
While there is still no approved drug treatment to reduce the main symptoms of autism, a study published in the journal Translational Psychiatry shows that artificial intelligence could be a game changer. By reanalyzing data from large clinical trials previously considered negative using machine learning algorithms, researchers show that, when certain clinical profiles are taken into account, … Read more
